XTEND

Evaluation of an extended and proactive dosing regimen in treatment-naïve patients with wet age-related macular degeneration

Study Type  : Observational
Actual Enrollment  : 1563 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of an eXtended and proacTive Dosing regimEn in Treatment-Naïve Patients With Wet Age-related Macular Degeneration (wAMD)
Actual Study Start Date  : May 12, 2019
Estimated Primary Completion Date  : July 15, 2023
Estimated Study Completion Date  : August 15, 2023

Related Publications

Our Affiliates